Stock Yearly Return 2022
Start date: 01/03/2022
End date: 12/30/2022
Start price/share: $12.80
End price/share: $0.39
Dividends collected/share: $0.00
Total return: -96.95%
TNXP Average Annual Return: -98.03%
Starting investment: $10,000.00
Ending investment: $305.00
Years: 0.99


TNXP average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare TNXP average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into TNXP


Also see:
TNXP YTD return
TNXP average annual return 10 years
Tonix Pharmaceuticals Holding is a clinical-stage biopharmaceutical company focused on discovering, cquiring and developing therapeutics and diagnostics to treat and prevent human disease. Co.'s portfolio is primarily composed of immunology, central nervous system (CNS), and infectious disease product candidates. Co.'s key product candidate within its immunology pipeline is TNX-1500, a humanized monoclonal antibody, directed against CD40-ligand, engineered to modulate binding to Fc receptors, that is being developed as a prophylaxis against organ transplant rejection. Among the CNS candidates in development is TNX-1300 which is for the treatment of life-threatening cocaine intoxication. The TNXP stock yearly return is shown above.

The yearly return on the TNXP stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2022 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the TNXP annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes

Email EnvelopeFree TNXP Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Tonix Pharmaceuticals Holding (TNXP) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

TNYA Average Annual Return
TPST Average Annual Return
TRVI Average Annual Return
TRVN Average Annual Return
TSHA Average Annual Return
TSVT Average Annual Return
TTNP Average Annual Return
TTOO Average Annual Return
TVTX Average Annual Return
TWST Average Annual Return
More Healthcare companies »

 

TNXP Stock Yearly Return 2022 | www.AverageAnnualReturn.com | Copyright © 2021 - 2023, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.